Circulating Pv-1 As A Marker of Celiac Disease-Associated Liver Injury

References

• Husby S , KoletzkoS, Korponay-SzabóIRet al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr.54(1), 136–160 (2012).
   PubMed Web of Science ®Google Scholar
• Jericho H , SansottaN, GuandaliniS. Extraintestinal manifestations of celiac disease: effectiveness of the gluten-free diet. J. Pediatr. Gastroenterol. Nutr.65(1), 75–79 (2017).
   PubMed Web of Science ®Google Scholar
• Pinto-Sánchez MI , BercikP, VerduEF, BaiJC. Extraintestinal manifestations of celiac disease. Dig. Dis.33(2), 147–154 (2015).
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A , MurrayJA. The liver in celiac disease. Hepatology46(5), 1650–1658 (2007).
   PubMed Web of Science ®Google Scholar
• Marciano F , SavoiaM, VajroP. Celiac disease-related hepatic injury: insights into associated conditions and underlying pathomechanisms. Dig. Liver Dis.48(2), 112–119 (2016).
   PubMedGoogle Scholar
• Bardella MT , FraquelliM, QuatriniM, MolteniN, BianchiP, ConteD. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology22(3), 833–836 (1995).
   PubMed Web of Science ®Google Scholar
• Castillo NE , VangaRR, TheethiraTGet al. Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am. J. Gastroenterol.110(8), 1216–1222 (2015).
   PubMed Web of Science ®Google Scholar
• Korpimäki S , KaukinenK, CollinPet al. Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding. Am. J. Gastroenterol.106(9), 1689–1696 (2011).
   PubMed Web of Science ®Google Scholar
• Vajro P , PaolellaG. Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J. Pediatr. Gastroenterol. Nutr.56(6), 663–667 (2013).
   PubMed Web of Science ®Google Scholar
• Lee GJ , BoyleB, EdigerT, HillI. Hypertransaminasemia in newly diagnosed pediatric patients with celiac disease. J. Pediatr. Gastroenterol. Nutr.63(3), 340–343 (2016).
   PubMed Web of Science ®Google Scholar
• Benelli E , NaviglioS, DeLeo Let al. Changing epidemiology of liver involvement in children with celiac disease. J. Pediatr. Gastroenterol. Nutr.68(4), 547–551 (2019).
   PubMed Web of Science ®Google Scholar
• Äärelä L , NurminenS, KiveläLet al. Prevalence and associated factors of abnormal liver values in children with celiac disease. Dig. Liver Dis.48(9), 1023–1029 (2016).
   PubMedGoogle Scholar
• Bardella MT , VecchiM, ConteDet al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology29, 654–657 (1999).
   PubMed Web of Science ®Google Scholar
• Bardella MT , ValentiL, PagliariCet al. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis.36(5), 333–336 (2004).
   PubMedGoogle Scholar
• Mounajjed T , OxentenkoA, ShmidtE, SmyrkT. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am. J. Clin. Pathol.136(1), 128–137 (2011).
   PubMed Web of Science ®Google Scholar
• Korponay-Szabó IR , HalttunenT, SzalaiZet al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut53(5), 641–648 (2004).
   PubMed Web of Science ®Google Scholar
• Heymann F , TackeF. Immunology in the liver: from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol.13(2), 88–110 (2016).
   PubMed Web of Science ®Google Scholar
• Spadoni I , ZagatoE, BertocchiAet al. A gut–vascular barrier controls the systemic dissemination of bacteria. Science350(6262), 830–834 (2015).
   PubMed Web of Science ®Google Scholar
• Guo L , ZhangH, HouY, WeiT, LiuJ. Plasmalemma vesicle–associated protein: a crucial component of vascular homeostasis. Exp. Ther. Med.12(3), 1639–1644 (2016).
   PubMed Web of Science ®Google Scholar
• Liebner S , CoradaM, BangsowTet al. Wnt/β-catenin signaling controls development of the blood–brain barrier. J. Cell Biol.183(3), 409–417 (2008).
   PubMed Web of Science ®Google Scholar
• Shue EH , Carson-WalterEB, LiuYet al. Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood–brain barrier disruption in rodent models. BMC Neurosci.9(1), 29 (2008).
   PubMedGoogle Scholar
• Wisniewska-Kruk J , vander Wijk A-E, van VeenHAet al. Plasmalemma vesicle-associated protein has a key role in blood–retinal barrier loss. Am. J. Pathol.186(4), 1044–1054 (2016).
   PubMed Web of Science ®Google Scholar
• Cheng C , TanJ, QianW, ZhangL, HouX. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: attention to the gut–vascular barrier dysfunction. Life Sci.209, 157–166 (2018).
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF , BaiJC, BiagiFet al. Diagnosis and management of adult coeliac disease: guidelines from the British society of gastroenterology. Gut63(8), 1210–1228 (2014).
   PubMed Web of Science ®Google Scholar
• Lowry OH , RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem.193(1), 265–275 (1951).
   PubMed Web of Science ®Google Scholar
• Strickland LA , JubbAM, HongoJAet al. Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J. Pathol.206(4), 466–475 (2005).
   PubMed Web of Science ®Google Scholar
• Faul F , ErdfelderE, BuchnerA, LangA-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods.41(4), 1149–1160 (2009).
   PubMed Web of Science ®Google Scholar
• Shiner M . Ultrastructural changes suggestive of immune reactions in the jejunal mucosa of coeliac children following gluten challenge. Gut14(1), 1–12 (1973).
   PubMed Web of Science ®Google Scholar
• Myrsky E , KaukinenK, SyrjänenM, Korponay-SzabóIR, MäkiM, LindforsK. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin. Exp. Immunol.152(1), 111–119 (2008).
   PubMed Web of Science ®Google Scholar
• Myrsky E , CajaS, Simon-VecseiZet al. Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA. Cell. Mol. Life Sci.66(20), 3375–3385 (2009).
   PubMed Web of Science ®Google Scholar